ROSM specialized in advanced regenerative musculoskeletal treatment, advocacy, and research.
ROSM has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
ROSM's investors include Maryland Stem Cell Research Fund (MSCRF).
ROSM is headquartered in Washington, United States.
ROSM specialized in advanced regenerative musculoskeletal treatment, advocacy, and research.
ROSM is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ROSM — Funding & Investors." VCBacked, December 30, 2025, https://www.vcbacked.co/company/rosm. Accessed September 30, 2026.
VCBacked. (2025). ROSM — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/rosm
{{cite web |title=ROSM — Funding & Investors |url=https://www.vcbacked.co/company/rosm |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated